Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sanjay Divakaran, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Sanjay Divakaran and Ron Blankstein.
Sanjay Divakaran
Connection Strength
8.852
Ron Blankstein
  1. FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis. J Nucl Cardiol. 2021 Oct 04.
    View in: PubMed
    Score: 0.962
  2. Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma: The YOUNG-MI Registry. JACC CardioOncol. 2021 Jun; 3(2):319-321.
    View in: PubMed
    Score: 0.942
  3. Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry. Diabetes Care. 2020 08; 43(8):1843-1850.
    View in: PubMed
    Score: 0.836
  4. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3.
    View in: PubMed
    Score: 0.692
  5. Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management. Br J Radiol. 2015 Feb; 88(1046):20140594.
    View in: PubMed
    Score: 0.600
  6. Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry. Eur J Prev Cardiol. 2022 03 11; 29(2):352-359.
    View in: PubMed
    Score: 0.248
  7. Impact of coronary artery calcium testing on patient management. J Cardiovasc Comput Tomogr. 2021 Dec 17.
    View in: PubMed
    Score: 0.244
  8. Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol. 2021 Nov 24.
    View in: PubMed
    Score: 0.243
  9. Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry. JAMA Cardiol. 2021 08 01; 6(8):880-888.
    View in: PubMed
    Score: 0.238
  10. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. Eur J Prev Cardiol. 2021 07 23; 28(8):e12-e14.
    View in: PubMed
    Score: 0.237
  11. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry. Clin Cardiol. 2020 Nov; 43(11):1209-1215.
    View in: PubMed
    Score: 0.223
  12. Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry. JAMA Netw Open. 2020 07 01; 3(7):e209649.
    View in: PubMed
    Score: 0.220
  13. Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2020 06 09; 75(22):2804-2815.
    View in: PubMed
    Score: 0.220
  14. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults. J Am Coll Cardiol. 2020 03 10; 75(9):1003-1013.
    View in: PubMed
    Score: 0.216
  15. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2021 10; 28(5):1988-1997.
    View in: PubMed
    Score: 0.211
  16. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. Am J Med. 2020 05; 133(5):605-612.e1.
    View in: PubMed
    Score: 0.211
  17. Response by Divakaran et al to Letter Regarding Article, "Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: An Imaging-Histologic Correlation Study in Patients Undergoing Cardiac Transplantation". Circ Cardiovasc Imaging. 2019 08; 12(8):e009622.
    View in: PubMed
    Score: 0.207
  18. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.205
  19. Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction. Circulation. 2018 12 11; 138(24):2855-2857.
    View in: PubMed
    Score: 0.198
  20. When Can We Defer Testing for Patients With Stable Chest Pain? JACC Cardiovasc Imaging. 2018 09; 11(9):1311-1314.
    View in: PubMed
    Score: 0.194
  21. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2018 06 05; 71(22):2540-2551.
    View in: PubMed
    Score: 0.188
  22. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clin Cardiol. 2017 Nov; 40(11):955-961.
    View in: PubMed
    Score: 0.181
  23. Enhanced Education for Noninvasive Cardiac Testing. JAMA Intern Med. 2017 05 01; 177(5):746.
    View in: PubMed
    Score: 0.177
  24. Incremental prognostic value of kidney function decline over coronary artery disease for cardiovascular event prediction after coronary computed tomography. Kidney Int. 2015 Jul; 88(1):152-9.
    View in: PubMed
    Score: 0.151
  25. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.144
  26. Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. JAMA Cardiol. 2022 01 01; 7(1):93-99.
    View in: PubMed
    Score: 0.061
  27. Cardiac Sarcoidosis: When and How to Treat Inflammation. Card Fail Rev. 2021 Mar; 7:e17.
    View in: PubMed
    Score: 0.061
  28. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2021 Sep 07.
    View in: PubMed
    Score: 0.060
  29. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2022 02; 15(2):312-321.
    View in: PubMed
    Score: 0.060
  30. Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. J Am Heart Assoc. 2021 07 06; 10(13):e018555.
    View in: PubMed
    Score: 0.059
  31. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 11; 14(11):2212-2220.
    View in: PubMed
    Score: 0.058
  32. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2021 12; 28(6):2976-2987.
    View in: PubMed
    Score: 0.055
  33. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.055
  34. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb; 29(1):37-42.
    View in: PubMed
    Score: 0.055
  35. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.053
  36. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.051
  37. Management of Coronary Artery Calcium and Coronary CTA Findings. Curr Cardiovasc Imaging Rep. 2015; 8(6):18.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.